Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer

INTRODUCTION: Ovarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or late recurrence and therapeutically target these m...

Descripción completa

Detalles Bibliográficos
Autores principales: Adzibolosu, Nicholas, Alvero, Ayesha B., Ali-Fehmi, Rouba, Gogoi, Radhika, Corey, Logan, Tedja, Roslyn, Chehade, Hussein, Gogoi, Vir, Morris, Robert, Anderson, Matthew, Vitko, Julie, Lam, Clarissa, Craig, Douglas B., Draghici, Sorin, Rutherford, Thomas, Mor, Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331425/
https://www.ncbi.nlm.nih.gov/pubmed/37435088
http://dx.doi.org/10.3389/fimmu.2023.1204148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331425/
https://www.ncbi.nlm.nih.gov/pubmed/37435088
http://dx.doi.org/10.3389/fimmu.2023.1204148

Ejemplares similares